We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Below we will list the departments and units that form part of Vall d’Hebron Hospital and the main diseases that we treat. We will also make recommendations based on advice backed up by scientific evidence that has been shown to be effective in guaranteeing well-being and quality of life.
Vols saber com serà la teva estada a l’Hospital Universitari Vall d’Hebron? Aquí trobaràs tota la informació.
Speaker: Victor José Gallardo López, Headache and Neurological Pain (VHIR)
Several pilot studies have studied the role of microRNAs (miRNAs) in migraine. However, the studies are hardly comparable and reproducible due to the high degree of heterogeneity that exists between the groups. Today we have clear evidence that the intrinsic factors related to the disease along with other environmental factors can influence epigenetic mechanisms and identifying them is crucial to find unbiased epigenetic markers. The main objective of this work is to identify and validate a differential expression pattern of miRNAs in peripheral blood mononuclear cells (PBMC) in a very well controlled cohort of individuals with migraine versus healthy controls (HC). To achieve this goal, experimental design based on three sequential studies was performed, including: (a) an exploratory study to estimate the effect of the analysis and adjust the sample size for (b) the main study, and finally replicate the findings in a third stage in a (c) validation study.
Víctor J. Gallardo, is a biotechnologist with interest in the field of bioinformatics, data science and algorithm design. He obtained his B.Sc. in Biotechnology at the Universitat de Barcelona (UB) when he started the bioinformatics, experimental design and data analysis programme. Then he worked during 6 months in Dr. Rovira’s group in the field of theoretical chemistry and computational biology. Then he applied for the M.Sc. in Bioinformatics for Health Science from the Universitat Pompeu Fabra (UPF). This MSc provided him the knowledge and expertise in the field of computer science, information engineering, mathematics and advanced statistical methods to analyze and interpret biological data. He also started a B.S. in Informatics Engineering in order to improve their programming and logical reasoning skills in the Universitat Oberta de Catalunya (UOC).
Since 2016, he has worked in the Headache and neurological pain research group of the Vall d’Hebron Research Institute (VHIR) directed by Dr. Pozo-Rosich. He has authored 26 papers in peer-reviewed journals, H index of 11. He has participated in national and international congresses and he is finishing his PhD in the field of epigenetics in migraine. Moreover, he has also worked as an associated professor (2019-2021) in the Engineering school of the Universitat Autònoma de Barcelona (UAB).
Host: Dra. Patricia Pozo Rosich, Head of group Headache and Neurological Pain (VHIR)
Register here to attend by Zoom: https://gencat.zoom.us/j/95456500439
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights". Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut. Purpose: Manage the user’s contact information. Legitimisation: Express acceptance of the privacy policy. Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use. Source: The interested party themselves.